Trials / Sponsors / Veralox Therapeutics
Veralox Therapeutics
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia Thrombocytopenia, Immune, Heparin Induced Thrombocytopenia | Phase 2 | 2023-09-26 |
| Completed | A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects Heparin-induced Thrombocytopenia | Phase 1 | 2022-03-07 |
| Completed | Phase I Study of VLX-1005 in Healthy Subjects Safety and Tolerability in Healthy Volunteers | Phase 1 | 2021-03-24 |